{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:16:26Z","timestamp":1777076186907,"version":"3.51.4"},"reference-count":37,"publisher":"American Society for Microbiology","issue":"8","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Vaccine Immunol"],"published-print":{"date-parts":[[2008,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p><jats:italic>Trypanosoma cruzi<\/jats:italic>is the etiologic agent of Chagas' disease, a major health problem in Latin America and an emerging infectious disease in the United States. Previously, we screened a<jats:italic>T. cruzi<\/jats:italic>sequence database by a computational-bioinformatic approach and identified antigens that exhibited the characteristics of good vaccine candidates. In this study, we tested the vaccine efficacy of three of the putative candidate antigens against<jats:italic>T. cruzi<\/jats:italic>infection and disease in a mouse model. C57BL\/6 mice vaccinated with<jats:italic>T. cruzi G1<\/jats:italic>(Tc<jats:italic>G1<\/jats:italic>)-, Tc<jats:italic>G2<\/jats:italic>-, or Tc<jats:italic>G4<\/jats:italic>-encoding plasmids and cytokine (interleukin-12 and granulocyte-macrophage colony-stimulating factor) expression plasmids elicited a strong Th1-type antibody response dominated by immunoglobulin G2b (IgG2b)\/IgG1 isotypes. The dominant IgG2b\/IgG1 antibody response was maintained after a challenge infection and was associated with 50 to 90% control of the acute-phase tissue parasite burden and an almost undetectable level of tissue parasites during the chronic phase, as determined by a sensitive<jats:italic>T. cruzi<\/jats:italic>18S rRNA gene-specific real-time PCR approach. Splenocytes from vaccinated-and-infected mice, compared to unvaccinated-and-infected mice, exhibited decreased (\u223c50% lower) proliferation and gamma interferon (IFN-\u03b3) production when stimulated in vitro with<jats:italic>T. cruzi<\/jats:italic>antigens, thus suggesting that protection from challenge infection was not provided by an active T-cell response. Subsequently, the serum and cardiac levels of IFN-\u03b3 and tumor necrosis factor alpha and infiltration of inflammatory infiltrate in the heart were decreased in vaccinated mice during the course of infection and chronic disease development. Taken together, these results demonstrate the identification of novel vaccine candidates that provided protection from<jats:italic>T. cruzi<\/jats:italic>-induced immunopathology in experimental mice.<\/jats:p>","DOI":"10.1128\/cvi.00144-08","type":"journal-article","created":{"date-parts":[[2008,6,13]],"date-time":"2008-06-13T01:14:16Z","timestamp":1213319656000},"page":"1158-1164","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":51,"title":["Previously Unrecognized Vaccine Candidates Control<i>Trypanosoma cruzi<\/i>Infection and Immunopathology in Mice"],"prefix":"10.1128","volume":"15","author":[{"given":"Vandanajay","family":"Bhatia","sequence":"first","affiliation":[{"name":"Departments of Microbiology and Immunology"},{"name":"Pathology, University of Texas Medical Branch, Galveston, Texas"},{"name":"Center for Biodefense and Emerging Infectious Diseases and Sealy Center for Vaccine Development, University of Texas Medical Branch, Galveston, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nisha Jain","family":"Garg","sequence":"additional","affiliation":[{"name":"Departments of Microbiology and Immunology"},{"name":"Pathology, University of Texas Medical Branch, Galveston, Texas"},{"name":"Center for Biodefense and Emerging Infectious Diseases and Sealy Center for Vaccine Development, University of Texas Medical Branch, Galveston, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1645\/0022-3395(2002)088[1107:RBLTRT]2.0.CO;2","volume":"88","year":"2002","unstructured":"Basombr\u00edo, M. A., M. A. Segura, and J. R. Nasser. 2002. Relationship between long-term resistance to Trypanosoma cruzi and latent infection, examined by antibody production and polymerase chain reaction in mice. J. Parasitol.88:1107-1112.","journal-title":"J. Parasitol."},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.72.11.6245-6254.2004"},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000237653","volume":"114","year":"1997","unstructured":"Brener, Z., and R. T. Gazzinelli. 1997. Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas' disease. Int. Arch. Allergy Immunol.114:103-110.","journal-title":"Int. Arch. Allergy Immunol."},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/icb.1989.50","volume":"67","year":"1989","unstructured":"Brodskyn, C. I., A. M. Silva, H. A. Takehara, and I. Mota. 1989. IgG subclasses responsible for immune clearance in mice infected with Trypanosoma cruzi. Immunol. Cell Biol.67(Pt. 6):343-348.","journal-title":"Immunol. Cell Biol."},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1084\/jem.182.5.1423","volume":"182","year":"1995","unstructured":"Campos-Neto, A., L. Soong, J. L. Cordova, D. Sant'Angelo, Y. A. Skeiky, N. H. Ruddle, S. G. Reed, C. Janeway, Jr., and D. McMahon-Pratt. 1995. Cloning and expression of a Leishmania donovani gene instructed by a peptide isolated from major histocompatibility complex class II molecules of infected macrophages. J. Exp. Med.182:1423-1433.","journal-title":"J. Exp. Med."},{"key":"e_1_3_2_7_2","first-page":"156","volume":"162","year":"1987","unstructured":"Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem.162:156-159.","journal-title":"Anal. Biochem."},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1590\/S0074-02761999000700042","volume":"94","year":"1999","unstructured":"Corr\u00eaa-Oliveira, R., J. Gomes, E. M. Lemos, G. M. Cardoso, D. D. Reis, S. Adad, E. Crema, O. A. Martins-Filho, M. O. Costa, G. Gazzinelli, and L. M. Bahia-Oliveira. 1999. The role of the immune response on the development of severe clinical forms of human Chagas disease. Mem. Inst. Oswaldo Cruz94(Suppl. 1):253-255.","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0264-410X(97)00277-6","volume":"16","year":"1998","unstructured":"Costa, F., G. Franchin, V. L. Pereira-Chioccola, M. Ribeirao, S. Schenkman, and M. M. Rodrigues. 1998. Immunization with a plasmid DNA containing the gene of trans-sialidase reduces Trypanosoma cruzi infection in mice. Vaccine16:768-774.","journal-title":"Vaccine"},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1590\/S0074-02761999000700044","volume":"94","year":"1999","unstructured":"de Lourdes Higuchi, M. 1999. Human chronic chagasic cardiopathy: participation of parasite antigens, subsets of lymphocytes, cytokines and microvascular abnormalities. Mem. Inst. Oswaldo Cruz94(Suppl. 1):263-267.","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.1112631","volume":"309","year":"2005","unstructured":"El-Sayed, N. M., P. J. Myler, D. C. Bartholomeu, D. Nilsson, G. Aggarwal, A. N. Tran, E. Ghedin, E. A. Worthey, A. L. Delcher, G. Blandin, S. J. Westenberger, E. Caler, G. C. Cerqueira, C. Branche, B. Haas, A. Anupama, E. Arner, L. Aslund, P. Attipoe, E. Bontempi, F. Bringaud, P. Burton, E. Cadag, D. A. Campbell, M. Carrington, J. Crabtree, H. Darban, J. F. da Silveira, P. de Jong, K. Edwards, P. T. Englund, G. Fazelina, T. Feldblyum, M. Ferella, A. C. Frasch, K. Gull, D. Horn, L. Hou, Y. Huang, E. Kindlund, M. Klingbeil, S. Kluge, H. Koo, D. Lacerda, M. J. Levin, H. Lorenzi, T. Louie, C. R. Machado, R. McCulloch, A. McKenna, Y. Mizuno, J. C. Mottram, S. Nelson, S. Ochaya, K. Osoegawa, G. Pai, M. Parsons, M. Pentony, U. Pettersson, M. Pop, J. L. Ramirez, J. Rinta, L. Robertson, S. L. Salzberg, D. O. Sanchez, A. Seyler, R. Sharma, J. Shetty, A. J. Simpson, E. Sisk, M. T. Tammi, R. Tarleton, S. Teixeira, S. Van Aken, C. Vogt, P. N. Ward, B. Wickstead, J. Wortman, O. White, C. M. Fraser, K. D. Stuart, and B. Andersson. 2005. The genome sequence of Trypanosoma cruzi, etiologic agent of Chagas disease. Science309:409-415.","journal-title":"Science"},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1016\/S0264-410X(03)00121-X","volume":"21","year":"2003","unstructured":"Fralish, B. H., and R. L. Tarleton. 2003. Genetic immunization with LYT1 or a pool of trans-sialidase genes protects mice from lethal Trypanosoma cruzi infection. Vaccine21:3070-3080.","journal-title":"Vaccine"},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1586\/14760584.4.6.867","volume":"4","year":"2005","unstructured":"Garg, N., and V. Bhatia. 2005. Current status and future prospects for a vaccine against American trypanosomiasis. Expert Rev. Vaccines4:867-880.","journal-title":"Expert Rev. Vaccines"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.10.5547-5555.2002"},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.4049\/jimmunol.158.7.3293","volume":"158","year":"1997","unstructured":"Garg, N., M. P. Nunes, and R. L. Tarleton. 1997. Delivery by Trypanosoma cruzi of proteins into the MHC class I antigen processing and presentation pathway. J. Immunol.158:3293-3302.","journal-title":"J. Immunol."},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0925-4439(03)00060-7","volume":"1638","year":"2003","unstructured":"Garg, N., V. L. Popov, and J. Papaconstantinou. 2003. Profiling gene transcription reveals a deficiency of mitochondrial oxidative phosphorylation in Trypanosoma cruzi-infected murine hearts: implications in chagasic myocarditis development. Biochim. Biophys. Acta1638:106-120.","journal-title":"Biochim. Biophys. Acta"},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1042\/BJ20040356","volume":"381","year":"2004","unstructured":"Garg, N., V. Bhatia, A. Gerstner, J. deFord, and J. Papaconstantinou. 2004. Gene expression analysis in mitochondria from chagasic mice: alterations in specific metabolic pathways. Biochem. J.381:743-752.","journal-title":"Biochem. J."},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1002\/eji.1830221006","volume":"22","year":"1992","unstructured":"Gazzinelli, R. T., I. P. Oswald, S. Hieny, S. L. James, and A. Sher. 1992. The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an l-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-beta. Eur. J. Immunol.22:2501-2506.","journal-title":"Eur. J. Immunol."},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1365-2958.1994.tb00306.x","volume":"11","year":"1994","unstructured":"Harth, G., A. A. Mills, T. Lin, and F. G. Araujo. 1994. Trypanosoma cruzi glycoprotein of Mr 56,000 characterization and assessment of its potential to protect against fatal parasite infections. Mol. Microbiol.11:261-271.","journal-title":"Mol. Microbiol."},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1056\/NEJM199308263290909","volume":"329","year":"1993","unstructured":"Kirchhoff, L. V. 1993. American trypanosomiasis (Chagas' disease)\u2014a tropical disease now in the United States. N. Engl. J. Med.329:639-644.","journal-title":"N. Engl. J. Med."},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"706","DOI":"10.2741\/1255","volume":"9","year":"2004","unstructured":"Kirchhoff, L. V., L. M. Weiss, M. Wittner, and H. B. Tanowitz. 2004. Parasitic diseases of the heart. Front. Biosci.9:706-723.","journal-title":"Front. Biosci."},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF00934390","volume":"77","year":"1991","unstructured":"Lima, M. T., A. M. Jansen, E. Rondinelli, and C. R. Gattass. 1991. Trypanosoma cruzi: properties of a clone isolated from CL strain. Parasitol. Res.77:77-81.","journal-title":"Parasitol. Res."},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.4049\/jimmunol.160.4.1817","volume":"160","year":"1998","unstructured":"Low, H. P., M. A. Santos, B. Wizel, and R. L. Tarleton. 1998. Amastigote surface proteins of Trypanosoma cruzi are targets for CD8+ CTL. J. Immunol.160:1817-1823.","journal-title":"J. Immunol."},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.10.6558-6563.2001"},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1365-3024.1993.tb00603.x","volume":"15","year":"1993","unstructured":"Powell, M. R., and D. L. Wassom. 1993. Host genetics and resistance to acute Trypanosoma cruzi infection in mice. I. Antibody isotype profiles. Parasite Immunol.15:215-221.","journal-title":"Parasite Immunol."},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s004360050406","volume":"84","year":"1998","unstructured":"Pyrrho, A. S., J. L. Moraes, L. M. Pecanha, and C. R. Gattass. 1998. Trypanosoma cruzi: IgG1 and IgG2b are the main immunoglobulins produced by vaccinated mice. Parasitol. Res.84:333-337.","journal-title":"Parasitol. Res."},{"key":"e_1_3_2_27_2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0022-1759(93)90104-F","volume":"165","year":"1993","unstructured":"Reiner, S. L., S. Zheng, D. B. Corry, and R. M. Locksley. 1993. Constructing polycompetitor cDNAs for quantitative PCR. J. Immunol. Methods165:37-46.","journal-title":"J. Immunol. Methods"},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"637","DOI":"10.4269\/ajtmh.1993.48.637","volume":"48","year":"1993","unstructured":"Reis, D. D., E. M. Jones, S. Tostes, Jr., E. R. Lopes, G. Gazzinelli, D. G. Colley, and T. L. McCurley. 1993. Characterization of inflammatory infiltrates in chronic chagasic myocardial lesions: presence of tumor necrosis factor-\u03b1+ cells and dominance of granzyme A+, CD8+ lymphocytes. Am. J. Trop. Med. Hyg.48:637-644.","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.61.12.5129-5133.1993"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.64.4.1093-1099.1996"},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0035-9203(85)90061-6","volume":"79","year":"1985","unstructured":"Scott, M. T., R. A. Neal, and N. C. Woods. 1985. Immunization of marmosets with Trypanosoma cruzi cell surface glycoprotein (GP90). Trans. R. Soc. Trop. Med. Hyg.79:451-454.","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.9.4986-4991.2000"},{"key":"e_1_3_2_33_2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1590\/S0001-37652003000200005","volume":"75","year":"2003","unstructured":"Soares, M. B., R. Goncalves, A. S. Pyrrho, D. A. Costa, C. N. Paiva, and C. R. Gattass. 2003. Balanced cytokine-producing pattern in mice immunized with an avirulent Trypanosoma cruzi. An. Acad. Bras. Cienc.75:167-172.","journal-title":"An. Acad. Bras. Cienc."},{"key":"e_1_3_2_34_2","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S1286-4579(00)00388-9","volume":"2","year":"2000","unstructured":"Talvani, A., C. S. Ribeiro, J. C. Aliberti, V. Michailowsky, P. V. Santos, S. M. Murta, A. J. Romanha, I. C. Almeida, J. Farber, J. Lannes-Vieira, J. S. Silva, and R. T. Gazzinelli. 2000. Kinetics of cytokine gene expression in experimental chagasic cardiomyopathy: tissue parasitism and endogenous IFN-\u03b3 as important determinants of chemokine mRNA expression during infection with Trypanosoma cruzi. Microbes Infect.2:851-866.","journal-title":"Microbes Infect."},{"key":"e_1_3_2_35_2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1046\/j.0818-9641.2002.01136.x","volume":"81","year":"2003","unstructured":"Vasconcelos, J. R., S. B. Boscardin, M. I. Hiyane, S. S. Kinoshita, A. E. Fujimura, and M. M. Rodrigues. 2003. A DNA-priming protein-boosting regimen significantly improves type 1 immune response but not protective immunity to Trypanosoma cruzi infection in a highly susceptible mouse strain. Immunol. Cell Biol.81:121-129.","journal-title":"Immunol. Cell Biol."},{"key":"e_1_3_2_36_2","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1590\/S0001-37652005000400009","volume":"77","year":"2005","unstructured":"Zacks, M. A., J. J. Wen, G. Vyatkina, V. Bhatia, and N. Garg. 2005. An overview of chagasic cardiomyopathy: pathogenic importance of oxidative stress. An. Acad. Bras. Cienc.77:695-715.","journal-title":"An. Acad. Bras. Cienc."},{"key":"e_1_3_2_37_2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/09687860600601494","volume":"23","year":"2006","unstructured":"Zacks, M. A., and N. Garg. 2006. Recent developments in the molecular, biochemical and functional characterization of GPI8 and GPI-anchoring mechanism. Mol. Membr. Biol.23:209-225.","journal-title":"Mol. Membr. Biol."},{"key":"e_1_3_2_38_2","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1086\/314889","volume":"180","year":"1999","unstructured":"Zhang, L., and R. L. Tarleton. 1999. Parasite persistence correlates with disease severity and localization in chronic Chagas' disease. J. Infect. Dis.180:480-486.","journal-title":"J. Infect. Dis."}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00144-08","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00144-08","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T20:08:53Z","timestamp":1684440533000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.00144-08"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["10.1128\/CVI.00144-08"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00144-08","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8]]},"assertion":[{"value":"2008-04-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2008-06-04","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}